Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (23740) 23740
Newsletter (2793) 2793
Publication (1820) 1820
Book Review (357) 357
Book Chapter (174) 174
Newspaper Article (60) 60
Dissertation (57) 57
Magazine Article (51) 51
Conference Proceeding (48) 48
Book / eBook (33) 33
Trade Publication Article (15) 15
Reference (9) 9
Web Resource (7) 7
Data Set (5) 5
Paper (4) 4
Transcript (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12755) 12755
male (9745) 9745
index medicus (9626) 9626
animals (8361) 8361
angiotensin (7954) 7954
hypertension (6822) 6822
female (6264) 6264
rats (4760) 4760
middle aged (4333) 4333
angiotensin ii type 1 receptor blockers - therapeutic use (4314) 4314
hypertension - drug therapy (4297) 4297
angiotensin-converting enzyme inhibitors - therapeutic use (4122) 4122
peripheral vascular disease (3829) 3829
aged (3677) 3677
research (3497) 3497
blood pressure - drug effects (3306) 3306
angiotensin ii (3178) 3178
angiotensin ii type 1 receptor blockers - pharmacology (3155) 3155
cardiac & cardiovascular systems (2927) 2927
pharmacology & pharmacy (2905) 2905
renin-angiotensin system (2898) 2898
antihypertensive agents - therapeutic use (2891) 2891
blood-pressure (2578) 2578
adult (2483) 2483
blood pressure (2482) 2482
treatment outcome (2473) 2473
angiotensin-ii (2444) 2444
risk factors (2302) 2302
renin-angiotensin system - drug effects (2277) 2277
hypertension - physiopathology (2108) 2108
heart failure (2075) 2075
drug therapy, combination (1981) 1981
tetrazoles - therapeutic use (1976) 1976
urology & nephrology (1946) 1946
losartan (1944) 1944
mice (1940) 1940
physiology (1912) 1912
drug therapy (1850) 1850
oxidative stress (1820) 1820
mortality (1784) 1784
diabetes (1766) 1766
tetrazoles - pharmacology (1737) 1737
rats, sprague-dawley (1658) 1658
valsartan (1651) 1651
angiotensin receptor antagonists (1579) 1579
angiotensin ii - pharmacology (1567) 1567
expression (1552) 1552
care and treatment (1513) 1513
angiotensin-converting enzyme inhibitors - pharmacology (1497) 1497
analysis (1480) 1480
losartan - pharmacology (1469) 1469
health aspects (1386) 1386
medicine (1374) 1374
time factors (1363) 1363
ace inhibitors (1351) 1351
enzymes (1345) 1345
disease models, animal (1331) 1331
reports (1323) 1323
renin-angiotensin system - physiology (1301) 1301
physiological aspects (1293) 1293
dose-response relationship, drug (1285) 1285
antihypertensive agents - pharmacology (1281) 1281
heart failure - drug therapy (1272) 1272
medicine, general & internal (1243) 1243
angiotensin ii receptor blockers (1227) 1227
hypertension - complications (1224) 1224
benzimidazoles - therapeutic use (1220) 1220
angiotensin ii type 1 receptor blockers - administration & dosage (1205) 1205
heart-failure (1177) 1177
benzimidazoles - pharmacology (1162) 1162
receptor, angiotensin, type 1 - metabolism (1161) 1161
angiotensin ii - metabolism (1151) 1151
renin (1148) 1148
rats, wistar (1145) 1145
inflammation (1106) 1106
valine - analogs & derivatives (1071) 1071
rodents (1060) 1060
adrenergic beta-antagonists - therapeutic use (1043) 1043
system (1043) 1043
aged, 80 and over (1031) 1031
endocrinology & metabolism (1029) 1029
prevention (1018) 1018
cells, cultured (1009) 1009
losartan - therapeutic use (1005) 1005
myocardial-infarction (978) 978
risk (974) 974
universities and colleges (972) 972
imidazoles - pharmacology (965) 965
telmisartan (959) 959
medical research (953) 953
disease (949) 949
calcium channel blockers - therapeutic use (946) 946
aldosterone (944) 944
angiotensin ii type 1 receptor blockers - adverse effects (931) 931
double-blind method (925) 925
medicine, research & experimental (925) 925
fibrosis (915) 915
inhibition (910) 910
enzyme inhibitors (904) 904
receptor (903) 903
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (25542) 25542
Japanese (365) 365
German (226) 226
Russian (142) 142
Chinese (129) 129
Spanish (125) 125
French (89) 89
Italian (57) 57
Korean (48) 48
Portuguese (24) 24
Polish (19) 19
Danish (18) 18
Czech (17) 17
Hungarian (15) 15
Swedish (11) 11
Dutch (8) 8
Turkish (8) 8
Norwegian (7) 7
Croatian (6) 6
Ukrainian (5) 5
Finnish (4) 4
Slovak (3) 3
Hebrew (2) 2
Persian (2) 2
Romanian (2) 2
Serbian (2) 2
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Angiotensin II receptor blockers
: a comparative effectiveness review
by Pohar, Ron and Farrah, Kelly and Canadian Electronic Library (Firm) and Canadian Agency for Drugs and Technologies in Health. Health Technology Inquiry Service
2008, Health technology inquiry service (HTIS)
Cardiovascular system | Prevention | Cardiovascular Diseases | Angiotensin Receptor Antagonists | Antagonists | prevention & control | Angiotensin II | Therapeutic use | Diseases
Web Resource
Details down arrow
2. Full Text Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality, Cardiovascular Deaths, and Cardiovascular Events in Patients With Diabetes Mellitus: A Meta-analysis
by Cheng, Jun and Zhang, Wen and Zhang, Xiaohui and Han, Fei and Li, Xiayu and He, Xuelin and Li, Qun and Chen, Jianghua
JAMA Internal Medicine, ISSN 2168-6106, 05/2014, Volume 174, Issue 5, pp. 773 - 785
IMPORTANCE Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) may have different effects on cardiovascular (CV)... 
Regression Analysis | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Cardiovascular Diseases - drug therapy | Cardiovascular Diseases - prevention & control | Humans | Diabetes Mellitus - drug therapy | Cardiovascular Diseases - mortality | Treatment Outcome | Angiotensin Receptor Antagonists - therapeutic use | Cause of Death | Diabetes Complications - prevention & control | Randomized Controlled Trials as Topic | Complications and side effects | Care and treatment | Usage | Mortality | Angiotensin II receptor blockers | Influence | Diabetes | Cardiovascular diseases | ACE inhibitors | Risk factors | Meta-analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Beneficial effects of Angiotensin II receptor blockers in brain disorders
by Saavedra, J.M
Pharmacological Research, ISSN 1043-6618, 11/2017, Volume 125, Issue Pt A, pp. 91 - 103
A canonical brain Renin-Angiotensin System (RAS), like the canonical peripheral RAS, has long been proposed as a major regulator of brain function. Because of... 
Neuroprotection | Traumatic and radiation brain injury | Brain Renin Angiotensin System | Neurodegenerative disorders | Angiotensin receptor blockers | DOPAMINERGIC DEGENERATION | ALZHEIMERS-DISEASE | CONVERTING ENZYME-INHIBITORS | IMMUNOREACTIVE ANGIOTENSIN | MESSENGER-RNA | PARAVENTRICULAR NUCLEUS | PHARMACOLOGY & PHARMACY | MAJOR DEPRESSIVE DISORDER | RAT-BRAIN | TYPE-2 DIABETES-MELLITUS | PARKINSONS-DISEASE | Brain - drug effects | Brain - metabolism | Brain Diseases - metabolism | Brain Diseases - drug therapy | Animals | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Receptor, Angiotensin, Type 1 - metabolism | Renin-Angiotensin System - drug effects | Angiotensin II Type 1 Receptor Blockers - pharmacology | Physiological aspects | Angiotensin | Brain | Nervous system diseases | Radiation | Brain damage | Development and progression | Injuries
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers for Treating Essential Hypertension
by David B. Matchar and Douglas C. McCrory and Lori A. Orlando and Manesh R. Patel and Uptal D. Patel and Meenal B. Patwardhan and Benjamin Powers and Gregory P. Samsa and Rebecca N. Gray
Annals of Internal Medicine, ISSN 0003-4819, 01/2008, Volume 148, Issue 1, pp. 16 - 29
Background: The relative effectiveness of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) for lowering blood... 
DIABETES-MELLITUS | MEDICINE, GENERAL & INTERNAL | ANTIHYPERTENSIVE MEDICATIONS | ARTERIAL-HYPERTENSION | MODERATE ESSENTIAL-HYPERTENSION | DOUBLE-BLIND | CANDESARTAN CILEXETIL | ELDERLY-PATIENTS | AMBULATORY BLOOD-PRESSURE | LEFT-VENTRICULAR HYPERTROPHY | RENAL PARENCHYMAL DISEASE | Angiotensin II Type 1 Receptor Blockers - adverse effects | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Risk Factors | Hypertension - drug therapy | Treatment Outcome | Antihypertensive Agents - therapeutic use | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Cardiovascular Diseases - epidemiology | Quality of Life | Adult | Hypertension | Dosage and administration | Drug therapy | ACE inhibitors | Angiotensin II receptor blockers
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Before Elective Noncardiac Surgery: An Ongoing Dilemma
by Setty, Sudarshan and Orza, Daniela and Belani, Kumar G
Anesthesia & Analgesia, ISSN 0003-2999, 09/2018, Volume 127, Issue 3, pp. 598 - 600
SYSTEM | BLOCKADE | ANESTHESIOLOGY | Angiotensin Receptor Antagonists | Angiotensin-Converting Enzyme Inhibitors | Risk Factors | Elective Surgical Procedures
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Abdominal Aortic Aneurysms: Nation-Wide Cohort Study
by Kristensen, Karl Emil and Torp-Pedersen, Christian and Gislason, Gunnar Hilmar and Egfjord, Martin and Rasmussen, Henrik Berg and Hansen, Peter Riis
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 03/2015, Volume 35, Issue 3, pp. 733 - 740
OBJECTIVE—The renin–angiotensin system is thought to play a pivotal role in the pathogenesis of abdominal aortic aneurysms (AAAs). However, effects of... 
aneurysm | cardiovascular diseases | hypertension | renin-angiotensin system | pharmacoepidemiology | SYSTEM | MANAGEMENT | INVOLVEMENT | DEFICIENT MICE | PREVALENCE | SCREENING-PROGRAM | HEART-ASSOCIATION | DISEASE | GROWTH | PERIPHERAL VASCULAR DISEASE | UPDATE | HEMATOLOGY | Aortic Aneurysm, Abdominal - diagnosis | Aortic Aneurysm, Abdominal - drug therapy | Aortic Aneurysm, Abdominal - mortality | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Proportional Hazards Models | Male | Treatment Outcome | Chi-Square Distribution | Incidence | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Time Factors | Aortic Aneurysm, Abdominal - physiopathology | Aged, 80 and over | Denmark - epidemiology | Female | Registries | Renin-Angiotensin System - drug effects | Vascular Surgical Procedures | Aged
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study
by Gitte Vrelits Sørensen and Patricia A. Ganz and Steven W. Cole and Lars A. Pedersen and Henrik Toft Sørensen and Deirdre P. Cronin-Fenton and Jens Peter Garne and Peer M. Christiansen and Timothy L. Lash and Thomas P. Ahern
Journal of Clinical Oncology, ISSN 0732-183X, 06/2013, Volume 31, Issue 18, pp. 2265 - 2272
Purpose To estimate associations between use of beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, or angiotensin receptor blockers (ARBs) and... 
SURVIVAL | SYSTEM | MORTALITY | ACE-INHIBITORS | TRIALS | CELLS | THERAPY | NOREPINEPHRINE | ONCOLOGY | COOPERATIVE GROUP | BLOCKADE | Risk Assessment - methods | Prospective Studies | Humans | Middle Aged | Risk Factors | Neoplasm Recurrence, Local | Proportional Hazards Models | Breast Neoplasms - drug therapy | Risk Assessment - statistics & numerical data | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Breast Neoplasms - pathology | Registries - statistics & numerical data | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Aged, 80 and over | Denmark | Adrenergic beta-Antagonists - adverse effects | Adult | Female | Aged | Breast Neoplasms - chemically induced | Angiotensin Receptor Antagonists - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Angiotensin Receptor Antagonists - adverse effects | Bc1 | ORIGINAL REPORTS | Bc8
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Cobalt‐Catalyzed CH Arylations with Weakly‐Coordinating Amides and Tetrazoles: Expedient Route to Angiotensin‐II‐Receptor Blockers
by Li, Jie and Ackermann, Lutz
Chemistry – A European Journal, ISSN 0947-6539, 04/2015, Volume 21, Issue 15, pp. 5718 - 5722
Cobalt‐catalyzed CH arylations enabled the synthesis of biaryl tetrazoles, which are key structural motifs in antihypertensive angiotensin‐II‐receptor... 
CH activation | amides | cobalt | tetrazoles | arylation | C-H activation | SYSTEM | ACTIVATION | AROMATIC IMINES | BOND FORMATION | ALKYLATIONS | ALKYNES | CHEMISTRY, MULTIDISCIPLINARY | ANTAGONISTS | EFFICIENT | HYDROARYLATION | VALSARTAN | Angiotensin Receptor Antagonists - chemical synthesis | Angiotensin Receptor Antagonists - chemistry | Tetrazoles - chemical synthesis | Tetrazoles - chemistry | Amides - chemical synthesis | Amides - chemistry | Catalysis | Benzamides - chemical synthesis | Cobalt - chemistry | Benzamides - chemistry | Drugs | Blocking | Amides | Tetrazoles | Synthesis | Benzamide
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Combined Effect of Angiotensin II Receptor Blocker and Either a Calcium Channel Blocker or Diuretic on Day-by-Day Variability of Home Blood Pressure: The Japan Combined Treatment With Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study
by Matsui, Yoshio and OʼRourke, Michael F and Hoshide, Satoshi and Ishikawa, Joji and Shimada, Kazuyuki and Kario, Kazuomi
Hypertension, ISSN 0194-911X, 06/2012, Volume 59, Issue 6, pp. 1132 - 1138
Day-by-day home blood pressure (BP) variability (BPV) was reported to be associated with increased cardiovascular risk. We aimed to test the hypothesis that... 
Home blood pressure | Pulse wave velocity | Day-by-day home blood pressure variability | Angiotensin II receptor blocker | Thiazide diuretic | Calcium channel blocker | thiazide diuretic | PREDICTOR | BAROREFLEX SENSITIVITY | OHASAMA | day-by-day home blood pressure variability | pulse wave velocity | HYPERTENSIVE PATIENTS | AMLODIPINE | INFARCTION | calcium channel blocker | HIGH-RISK | angiotensin II receptor blocker | DISEASE | PERIPHERAL VASCULAR DISEASE | HEART-RATE | home blood pressure | VISIT-TO-VISIT | Multivariate Analysis | Prospective Studies | Drug Administration Schedule | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Hypertension - drug therapy | Male | Treatment Outcome | Azetidinecarboxylic Acid - analogs & derivatives | Hypertension - physiopathology | Dihydropyridines - therapeutic use | Azetidinecarboxylic Acid - therapeutic use | Diuretics - therapeutic use | Female | Tetrazoles - therapeutic use | Aged | Blood Pressure - drug effects | Blood Pressure Monitoring, Ambulatory - methods | Imidazoles - therapeutic use | Drug Therapy, Combination | Hydrochlorothiazide - therapeutic use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Fimasartan-induced liver injury in a patient with no adverse reactions on other types of angiotensin II receptor blockers A case report
by Park, DH and Yun, GY and Eun, HS and Joo, JS and Kim, JS and Kang, SH and Moon, HS and Lee, ES and Lee, BS and Kim, KH and Kim, SH
MEDICINE, ISSN 0025-7974, 11/2017, Volume 96, Issue 47, p. e8905
Rationale: Angiotensin II receptor blockers (ARBs) are widely used for patients with hypertension, and fimasartan is a recently approved ARBs. Fimasartan can... 
drug-induced liver injury | MEDICINE, GENERAL & INTERNAL | LOSARTAN | SAFETY | CANDESARTAN | IRBESARTAN | fimasartan | HEPATIC-INJURY | angiotensin II receptor blockers | INDUCED HEPATOTOXICITY
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Evidence to Consider Angiotensin II Receptor Blockers for the Treatment of Early Alzheimer's Disease
by Saavedra, JM
CELLULAR AND MOLECULAR NEUROBIOLOGY, ISSN 0272-4340, 03/2016, Volume 36, Issue 2, pp. 259 - 279
Alzheimer's disease is the most frequent type of dementia and diagnosed late in the progression of the illness when irreversible brain tissue loss has already... 
Brain metabolism Brain ischemia | MICROVASCULAR INFLAMMATION | AT RECEPTOR | INNATE IMMUNE-RESPONSE | FACTOR-KAPPA-B | TYPE-1 RECEPTOR | NEUROSCIENCES | COGNITIVE FUNCTION | HYPERTENSIVE PATIENTS | CELL BIOLOGY | BRAIN-BARRIER PERMEABILITY | Brain inflammation | GLUCOSE-METABOLISM | Neurodegenerative diseases Angiotensin II | CEREBRAL-BLOOD-FLOW | Neurovascular coupling | Neuroprotective Agents - therapeutic use | Humans | Alzheimer Disease - drug therapy | Clinical Trials as Topic | Alzheimer Disease - pathology | Brain - drug effects | Brain - metabolism | Animals | Neuroprotective Agents - pharmacology | Alzheimer Disease - prevention & control | Brain - pathology | Angiotensin Receptor Antagonists - therapeutic use | Disease Models, Animal | Hypertension | Brain | Neurons | Development and progression | Glucose | Glutamate | Risk factors | Dextrose | Stroke (Disease) | Glucose metabolism | Chronic kidney failure | Analysis | Angiotensin | Physiological aspects | Drug therapy | Alzheimer's disease | Injuries
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Angiotensin II receptor blockers and cancer risk a meta-analysis of randomized controlled trials
by Zhao, Yun-Tao and Li, Peng-Yang and Zhang, Jian-Qiang and Wang, Lei and Yi, Zhong
Medicine (United States), ISSN 0025-7974, 2016, Volume 95, Issue 18, p. e3600
Angiotensin II receptor blockers (ARB) are widely used drugs that are proven to reduce cardiovascular disease events; however, several recentmeta-analyses... 
MORTALITY | CHRONIC HEART-FAILURE | MEDICINE, GENERAL & INTERNAL | CONVERTING-ENZYME INHIBITORS | MYOCARDIAL-INFARCTION | CARCINOMA CELLS | MORBIDITY | VENTRICULAR SYSTOLIC FUNCTION | CANDESARTAN | HYPERTENSION | VALSARTAN | Humans | Risk Factors | Drug Therapy, Combination | Angiotensin Receptor Antagonists - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Neoplasms - epidemiology | Incidence | Randomized Controlled Trials as Topic | Usage | Care and treatment | Cardiovascular diseases | Risk factors | Angiotensin II receptor blockers | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Population-Based Study of Statins, Angiotensin II Receptor Blockers, and Angiotensin-Converting Enzyme Inhibitors on Pneumonia-Related Outcomes
by Eric M. Mortensen and Brandy Nakashima and John Cornell and Laurel A. Copeland and Mary Jo Pugh and Antonio Anzueto and Chester Good and Marcos I. Restrepo and John R. Downs and Christopher R. Frei and Michael J. Fine
Clinical Infectious Diseases, ISSN 1058-4838, 12/2012, Volume 55, Issue 11, pp. 1466 - 1473
Background. Studies suggest that statins and angiotensin-converting enzyme (ACE) inhibitors might be beneficial for the treatment of infections. Our purpose... 
Pneumonia | Health outcomes | Diabetes complications | Angiotensin converting enzyme inhibitors | Mortality | Medications | Hospitalization | Diabetes | Artificial respiration | Length of stay | INFECTIOUS DISEASES | COMMUNITY-ACQUIRED PNEUMONIA | THERAPY | DISEASE | CYTOKINE LEVELS | MICROBIOLOGY | IMMUNOLOGY | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Humans | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Pneumonia - complications | Female | Male | Aged | Retrospective Studies | Odds Ratio | Population Surveillance | Angiotensin Receptor Antagonists - adverse effects | Cohort Studies | Care and treatment | Bacterial pneumonia | Chemical properties | Diagnosis | ACE inhibitors | Statistics | Patients | Health aspects | Risk factors | and Commentaries
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Angiotensin II receptor blockers are safe in patients with prior angioedema related to angiotensin‐converting enzyme inhibitors – a nationwide registry‐based cohort study
by Rasmussen, Eva Rye and Pottegård, Anton and Bygum, Anette and Buchwald, Christian and Homøe, Preben and Hallas, Jesper
Journal of Internal Medicine, ISSN 0954-6820, 05/2019, Volume 285, Issue 5, pp. 553 - 561
Background It has long been suggested that angiotensin‐converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (AT2s) have some degree of... 
angiotensin‐converting enzyme | therapeutics | angiotensins | hypertension | Angioedema | angiotensin-converting enzyme | MEDICINE, GENERAL & INTERNAL | ACE-INHIBITOR | ANTAGONISTS | EXPOSURE | Hypertension | Angioneurotic edema | Care and treatment | Calcium channels | Analysis | Calcium channel blockers | Angiotensin | Antihypertensive drugs | ACE inhibitors | Drugs | Enzymes | Calcium | Adjustment | Antihypertensives | Population studies | Hazards | Regression analysis | Incidence | Regression models | Inhibitors | Enzyme inhibitors | Calcium ion channel blockers | Converting | Health hazards | Angiotensin AT2 receptors | Thiazides | Angiotensin II | Health risk assessment
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Impact of the Commercialization of Three Generic Angiotensin II Receptor Blockers on Adverse Events in Quebec, Canada: A Population-Based Time Series Analysis
by Leclerc, Jacinthe and Blais, Claudia and Rochette, Louis and Hamel, Denis and Guénette, Line and Poirier, Paul
Circulation: Cardiovascular Quality and Outcomes, ISSN 1941-7713, 10/2017, Volume 10, Issue 10
Background-Once the patent of a brand-name drug expires, generic drugs are commercialized, and substitution from brand-name to generics may occur. Generic drug... 
generic drugs | adverse events complications | brand-name drugs | angiotensin II receptor blockers | pharmacoepidemiology | POTENTIAL SAVINGS | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | THERAPEUTIC SUBSTITUTION | CLINICAL CONSEQUENCES | EQUIVALENCE | ATRIAL-FIBRILLATION | WARFARIN | CARDIOVASCULAR-DISEASE | SURVEILLANCE | Drug Costs | Humans | Patient Admission | Tetrazoles - economics | Drugs, Generic - economics | Hypertension - drug therapy | Benzimidazoles - economics | Angiotensin Receptor Antagonists - economics | Drugs, Generic - therapeutic use | Time Factors | Valsartan - therapeutic use | Patient Safety | Hypertension - mortality | Retrospective Studies | Benzimidazoles - adverse effects | Hypertension - diagnosis | Drug Substitution - adverse effects | Hypertension - economics | Antihypertensive Agents - economics | Benzimidazoles - therapeutic use | Databases, Factual | Losartan - economics | Emergency Service, Hospital | Quebec - epidemiology | Drug Substitution - economics | Risk Factors | Valsartan - adverse effects | Treatment Outcome | Antihypertensive Agents - therapeutic use | Antihypertensive Agents - adverse effects | Drugs, Generic - adverse effects | Losartan - therapeutic use | Losartan - adverse effects | Tetrazoles - therapeutic use | Referral and Consultation | Tetrazoles - adverse effects | Valsartan - economics | Angiotensin Receptor Antagonists - therapeutic use | Population Surveillance | Angiotensin Receptor Antagonists - adverse effects | Therapeutic Equivalency
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights